Enteric-coated aspirin is generally referred to as aspirin enteric-coated tablets, and baisinomide is generically known as nifedipine controlled-release tablets. It is possible to take the drug together if the user does not have contraindications to both drugs. Aspirin enteric-coated tablets can be used as a non-steroidal anti-inflammatory drug, anti-platelet aggregation drugs, used in the treatment of unstable angina, acute myocardial infarction, etc.; nifedipine controlled-release tablets are suitable for the treatment of hypertension, coronary heart disease, chronic stabilized angina. If the patient does not exist two drugs contraindications, can be taken together, but need to follow the doctor’s instructions for medication. Some patients may experience adverse reactions such as indigestion and abdominal pain after taking aspirin enteric-coated tablets. Aspirin enteric-coated tablets are contraindicated if the patient is allergic to aspirin or any other ingredient in the drug. Aspirin enteric-coated tablets are also contraindicated in patients with acute gastrointestinal ulcers, bleeding disorders, the last trimester of pregnancy and severe hepatic, renal and cardiac failure. Some patients may experience adverse reactions such as dizziness, palpitations (rapid heartbeat, often accompanied by panic), and nausea with nifedipine controlled-release tablets. Nifedipine Controlled-Release Tablets are contraindicated if there is a known hypersensitivity to nifedipine or any of the ingredients in this product. Nifedipine Controlled-Release Tablets are also contraindicated in special populations such as cardiogenic shock, pregnancy within 20 weeks, lactating women, and ileostomy after recto-colonic resection. It is recommended that patients take aspirin enteric-coated tablets and nifedipine controlled-release tablets under the guidance of a doctor, and should not use the medication or adjust the dosage at will.